GlassScriptPhysician profile
Jackson W Deere
NPI 1497311369
$1,672.60
in general payments reported to CMS, 2019-2025
14 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,206 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886 · Travel and Lodging: $752 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.24 |
| Travel and Lodging | $752.36 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $882.17 | 2024-2025 | Inspire |
| Depuy Synthes Sales INC. | $201.43 | 2024-2025 | Trumatch, Matrixmandible, Matrixwave |
| Genzyme Corporation | $151.52 | 2024-2025 | |
| Amgen INC. | $83.84 | 2024-2025 | Tavneos, Tezspire |
| Regeneron Healthcare Solutions, INC. | $62.72 | 2024-2025 | Dupixent, Libtayo |
| Baxter Healthcare | $55.37 | 2025 | Perclot |
| Abbvie INC. | $55.19 | 2024-2025 | |
| Cochlear Americas | $46.14 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Smith+Nephew, INC. | $39.83 | 2025 | Tula |
| Astrazeneca Pharmaceuticals LP | $23.60 | 2024 | Tezspire |
| Novartis Pharmaceuticals Corporation | $20.59 | 2025 | |
| Aesculap, INC. | $20.08 | 2024 | Anatomics Acrylic Cranial Implant |
| Optinose US, INC. | $16.19 | 2024 | |
| Aerin Medical INC. | $13.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Deere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.